FDA DEVICE FACTS
CarboClear Lumbar Cage System
Carbofix Orthpedics , Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The CarboClear® Lumbar Cage System is indicated for intervertebral body fusion of the lumbar spine in skeletally mature patients w ith degenerative disc disease (DDD), at one or two contiguous levels from L2 to S1. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The patients may also have up to Grade I spondylolisthesis at the involved levels. CarboClear® Lumbar Cage System is intended for use with autogenous bone graft and/or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft, and with supplemental fixation cleared for use in the lumbosacral spine. Patients should have at least six months of non-operative treatment prior to surgery. System Description CarboClear ® Lumbar Cage System is composed of implants of various sizes and lordotic angles, and instruments. The CarboClear® Lumbar Cage is made of carbon fiber-reinforced polyetheretherketone (CFR-PEEK), with titanium alloy endplates. It is implanted in the intervertebral disc space with bone graft and is designed to main tain disc height and to facilitate vertebral fusion. The CarboClear ® Lumbar Cage System should be used with a supplemental fixation system. CARBOFIX ORTHOPEDICS LTD. CARBOCLEAR® LUMBAR CAGE SYSTEM Purpose of Submission The purpose of this Special 510(k) Premarket Notification is to add lordotic lumbar cages to the CarboClear® Lumbar Cage System. Performance Data and Substantial Equivalence The intended use, design, material, dimensions, technological characteristics, and principles of operation of the subject CarboClear ® Lumbar Cage System are substantially equivalent to those of the predicate devices. Performance characteristics included finite element analysis with supportive testing according to ASTM F2077 and expulsion test. The results of the analysis/tests are comparable to those of the predicate device s, demonstrating substantially equivalent mechanical performance of the subject device.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。